🕵️ Dynavax Technologies Corporation ($DVAX)
SEC insider & ownership activity, last 12 months · CIK 1029142 · every row links its SEC filing
Over the last 12 months insiders sold $24.6M against $41K of open-market buying. DEEP Track Biotechnology Master Fund, Ltd. sold $22.4M in discretionary trades (Aug). One red-flag 8-K in the window: Delisting notice (3.01), Feb 10, 2026.
🚨 1 signal active —
planned-vs-executed verdicts, pre-event flags, and cluster context live in the
API and the
alerts bot.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
1 buyer, $41K (1 lots) · 2 sellers, $24.6M (4 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| DEEP Track Biotechnology Master Fund, Ltd. | 0 | – | 2 | $22.4M | Aug 22, 2025 |
| David Novack | 0 | – | 2 | $2.2M | Jan 15, 2026 |
| Myers Scott Dunseth | 1 | $41K | 0 | – | Aug 22, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Blackrock, Inc. | 14.2% | 13G | Jul 17, 2025 | filing ↗ | |
| DEEP Track Capital, LP | 13.5% | 13D | Feb 18, 2025 | filing ↗ | |
| DEEP Track Biotechnology Master Fund, Ltd. | 13.5% | 13D | Feb 18, 2025 | filing ↗ | |
| David Kroin | 13.5% | 13D | Feb 18, 2025 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| David Novack | $1.8M | Jan 15, 2026 | filing ↗ |
| David Novack | $465K | Dec 24, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Material agreement (1.01) | Feb 10, 2026 | filing ↗ |
| Agreement terminated (1.02) | Feb 10, 2026 | filing ↗ |
| Acquisition or disposition (2.01) | Feb 10, 2026 | filing ↗ |
| Delisting notice (3.01) | Feb 10, 2026 | filing ↗ |
| Material Modifications to Rights of Security Holders (3.03) | Feb 10, 2026 | filing ↗ |
| Change of control (5.01) | Feb 10, 2026 | filing ↗ |
| Officer/director changes (5.02) | Feb 10, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Feb 10, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 10, 2026 | filing ↗ |
| Material agreement (1.01) | Dec 23, 2025 | filing ↗ |
| Officer/director changes (5.02) | Dec 23, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Dec 23, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 23, 2025 | filing ↗ |
| Earnings (2.02) | Nov 5, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 5, 2025 | filing ↗ |
| Officer/director changes (5.02) | Oct 15, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Aug 21, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 21, 2025 | filing ↗ |
| Earnings (2.02) | Aug 7, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 7, 2025 | filing ↗ |